Roberta Bruhn1, Elizabeth Moreno2, Ester C Sabino3,4, Naura Aparecida F Ferreira5, Anna Barbara F Carneiro-Proietti2, Maria Esther D Lopes5, Divaldo Sampaio6, Paula Loureiro6,7, Brian Custer1, Thelma T Goncalez1. 1. Blood Systems Research Institute, Epidemiology, San Francisco, California. 2. Fundação Hemominas/Hemocentro de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. 3. Institute of Tropical Medicine, Universidade de São Paulo, São Paulo, Brazil. 4. Department of Infectious Disease, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil. 5. Hemocentro do Rio de Janeiro, Rio de Janeiro, Brazil. 6. Fundação Hemope/Hemocentro de Pernambuco, Recife, Pernambuco, Brazil. 7. University of Pernambuco, FCM, Fundação Hemope, Recife, Pernambuco, Brazil.
Abstract
BACKGROUND: There has been increased worldwide emphasis on the many benefits of human immunodeficiency virus (HIV) serostatus awareness for both infection prevention and improved treatment outcomes. Previous studies indicate that donors may use blood donation to be tested; the objectives of this analysis were to assess, among donors with previously undisclosed risk behavior in the 12 months before donation, the frequency of those who have previously been tested for HIV and the demographic and behavioral factors associated with such testing. STUDY DESIGN AND METHODS: In this secondary analysis from an HIV case-control study of blood donors in Brazil, we analyzed the response to the question, "Other than blood donation, have you ever been tested for HIV?" Demographic and disclosed risk behaviors associated with previous testing were determined. RESULTS: The study included 341 HIV-positive cases and 791 HIV-negative controls (1:2 case/control ratio). Overall, 31% of blood donors (40% of cases and 26% of controls) reported having been tested for HIV outside of blood donation. History of HIV testing varied according to sex, HIV status, and reported sexual risk behavior. CONCLUSION: Although it is encouraging that previous testing was more frequent in donors with acknowledged sexual risk behavior in Brazil, 60% still had not been tested for HIV outside of the blood donation setting. Educating donors on the importance of not using blood centers as a means to get tested for HIV in Brazil, especially if they engage in higher risk behaviors, and seeking alternate testing venues instead could improve the safety of donated blood.
BACKGROUND: There has been increased worldwide emphasis on the many benefits of human immunodeficiency virus (HIV) serostatus awareness for both infection prevention and improved treatment outcomes. Previous studies indicate that donors may use blood donation to be tested; the objectives of this analysis were to assess, among donors with previously undisclosed risk behavior in the 12 months before donation, the frequency of those who have previously been tested for HIV and the demographic and behavioral factors associated with such testing. STUDY DESIGN AND METHODS: In this secondary analysis from an HIV case-control study of blood donors in Brazil, we analyzed the response to the question, "Other than blood donation, have you ever been tested for HIV?" Demographic and disclosed risk behaviors associated with previous testing were determined. RESULTS: The study included 341 HIV-positive cases and 791 HIV-negative controls (1:2 case/control ratio). Overall, 31% of blood donors (40% of cases and 26% of controls) reported having been tested for HIV outside of blood donation. History of HIV testing varied according to sex, HIV status, and reported sexual risk behavior. CONCLUSION: Although it is encouraging that previous testing was more frequent in donors with acknowledged sexual risk behavior in Brazil, 60% still had not been tested for HIV outside of the blood donation setting. Educating donors on the importance of not using blood centers as a means to get tested for HIV in Brazil, especially if they engage in higher risk behaviors, and seeking alternate testing venues instead could improve the safety of donated blood.
Authors: Roland C Merchant; Bethany M Catanzaro; George R Seage; Kenneth H Mayer; Melissa A Clark; Victor G Degruttola; Bruce M Becker Journal: J Med Screen Date: 2009 Impact factor: 2.136
Authors: Jessika Deblonde; Herman Meulemans; Steven Callens; Stanley Luchters; Marleen Temmerman; Françoise F Hamers Journal: Health Policy Date: 2011-07-27 Impact factor: 2.980
Authors: Jessika Deblonde; Françoise F Hamers; Steven Callens; Raquel Lucas; Henrique Barros; Kristi Rüütel; Elina Hemminki; Marleen Temmerman Journal: AIDS Care Date: 2013-10-04
Authors: Kristen Mahle Gray; Tian Tang; Luke Shouse; Jianmin Li; Jonathan Mermin; H Irene Hall Journal: Am J Public Health Date: 2012-11-15 Impact factor: 9.308
Authors: Maurice Musheke; Harriet Ntalasha; Sara Gari; Oran McKenzie; Virginia Bond; Adriane Martin-Hilber; Sonja Merten Journal: BMC Public Health Date: 2013-03-11 Impact factor: 3.295